Related Experiment Video
Updated: Feb 28, 2026

Following Cell-fate in E. coli After Infection by Phage Lambda
Published on: October 14, 2011
Convergent MurJ flippase inhibition by phage lysis proteins
Yancheng E Li1, S Francesca Antillon2,3, Grace F Baron1
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Abstract:
Antimicrobial drug resistance poses a global health challenge that necessitates the identification of new druggable targets1-3. The essential lipid II flippase MurJ is a promising yet underexplored antimicrobial target in bacterial cell wall biosynthesis4-7. The only known inhibitors of Gram-negative (diderm) MurJ are the single-gene lysis proteins (Sgls) from the lytic single-strand RNA phages M (SglM) and PP7 (SglPP7)8,9. SglM and SglPP7 have distinct evolutionary origins and share no sequence similarity. Here we describe a common mechanism of MurJ inhibition by these phage-encoded Sgls. We determined the structures of MurJ-bound SglM and SglPP7 and discovered a third distinct MurJ-targeting Sgl from the predicted phage Changjiang3 (SglCJ3) that we also characterized structurally. Our findings demonstrate that all three Sgls evolved convergently to trap MurJ in a periplasm-open conformation through a common MurJ interface, revealing a pathway for drug design.
Insights
Antimicrobial drug resistance requires new targets. Phage proteins called single-gene lysis proteins (Sgls) inhibit the essential MurJ bacterial enzyme, offering a novel drug design strategy against Gram-negative bacteria.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- Antimicrobial drug resistance is a critical global health issue.
- The bacterial lipid II flippase MurJ is a key target for new antibiotics.
- Single-gene lysis proteins (Sgls) from phages M and PP7 are the only known inhibitors of Gram-negative MurJ.
Purpose of the Study:
- To elucidate the common mechanism of MurJ inhibition by phage-encoded Sgls.
- To identify and characterize novel Sgl inhibitors of MurJ.
- To reveal a potential pathway for designing new antimicrobial drugs.
Main Methods:
- Determined the structures of MurJ-bound SglM and SglPP7.
- Identified and structurally characterized a third MurJ-targeting Sgl, SglCJ3.
- Comparative structural analysis of Sgl-MurJ interactions.
Main Results:
- SglM, SglPP7, and SglCJ3 share a common mechanism for inhibiting MurJ.
- These Sgls convergently evolved to bind MurJ at a conserved interface.
- The inhibition mechanism involves trapping MurJ in a periplasm-open conformation.
Conclusions:
- Phage Sgls provide a conserved inhibitory mechanism against the essential bacterial MurJ.
- The structural insights into Sgl-MurJ interactions reveal a promising avenue for antimicrobial drug design.
- Convergent evolution offers a framework for developing novel inhibitors targeting bacterial cell wall biosynthesis.
Related Concept Videos
DNA Bacteriophages
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages

